AEVANOVA ANDROGEN SCIENCEAEVANOVA NAUKA O ANDROGENIMA
A source-led guide to anabolic-androgenic steroids: established medical use, nonmedical bodybuilding practice, health consequences, endocrine recovery and the limits of current evidence.Vodič kroz anaboličko-androgene steroide zasnovan na izvorima: utvrđena medicinska primena, nemedicinska bodibilding praksa, zdravstvene posledice, endokrini oporavak i granice aktuelnih dokaza.
Medical use · Performance context · Safety · Recovery · RegulationMedicinska primena · Kontekst performansi · Bezbednost · Oporavak · Regulativa
Reviewed 24 October 2026Pregledano 24. oktobar 2026.Start with definitionsPočnite definicijama
The same hormone can be a licensed treatment in one setting and a nonmedical performance drug in another. Indication, exposure, formulation and outcome determine how evidence should be interpreted.Isti hormon može biti registrovana terapija u jednom kontekstu i nemedicinska supstanca za performanse u drugom. Indikacija, izloženost, formulacija i ishod određuju kako treba tumačiti dokaze.
Compounds acting through the androgen receptor can differ in metabolism, formulation, tissue effects and evidence. The word anabolic does not mean non-androgenic or safe.Jedinjenja koja deluju preko androgenog receptora mogu se razlikovati po metabolizmu, formulaciji, efektima u tkivima i dokazima. Reč anabolički ne znači ne-androgeno niti bezbedno.
Prescribed testosterone replacement aims to treat documented hypogonadism within a clinical framework. That is different from supraphysiological performance use.Propisana nadoknada testosterona ima cilj da leči dokumentovani hipogonadizam u kliničkom okviru. To nije isto što i suprafiziološka upotreba radi performansi.
Cycles, stacks and post-cycle practices describe nonmedical behaviour. Their popularity does not establish efficacy, comparative safety or a universal recovery method.Ciklusi, kombinacije i post-cycle prakse opisuju nemedicinsko ponašanje. Njihova popularnost ne utvrđuje efikasnost, uporednu bezbednost niti univerzalan način oporavka.
Blood pressure, blood count, lipids, endocrine markers and organ assessment can reveal problems. Normal snapshots cannot prove that continued exposure is safe.Krvni pritisak, krvna slika, lipidi, endokrini markeri i procena organa mogu otkriti probleme. Uredan trenutni nalaz ne može dokazati da je nastavak izlaganja bezbedan.
Launch collectionPočetna kolekcija
Each article states the evidence level, separates observed practice from medical guidance and links directly to professional statements, clinical guidelines or peer-reviewed research.Svaki tekst navodi nivo dokaza, odvaja opisanu praksu od medicinskih smernica i vodi direktno ka stručnim stavovima, kliničkim smernicama ili recenziranim istraživanjima.
A molecule can have an established medical role while carrying a very different evidence and risk profile when used without an indication or at supraphysiological exposure.Molekul može imati utemeljenu medicinsku ulogu, a sasvim drugačiji profil dokaza i rizika kada se koristi bez indikacije ili pri suprafiziološkoj izloženosti.
The statement offers a practical evidence framework for health consequences, cessation and recovery—while openly acknowledging where formal guidance is not yet possible.Dokument nudi praktičan okvir dokaza za zdravstvene posledice, prekid i oporavak—uz otvoreno priznanje gde formalne smernice još nisu moguće.
Post-cycle therapy is widely discussed but remains scientifically unsettled. Hormonal recovery, symptom recovery and fertility are related—but not interchangeable outcomes.Post-cycle terapija se široko razmatra, ali naučno ostaje nerešena. Hormonski oporavak, oporavak simptoma i plodnost jesu povezani—ali nisu isti ishodi.
No single laboratory number captures androgen risk. The clinically relevant picture spans cardiovascular structure, blood and lipids, reproductive suppression and compound-specific organ toxicity.Nijedan pojedinačni laboratorijski broj ne obuhvata rizik androgena. Klinički relevantna slika uključuje strukturu srca, krv i lipide, reproduktivnu supresiju i toksičnost organa specifičnu za jedinjenje.
Risk is a systemRizik je sistem
Analytical purity answers what is in a sample. Clinical monitoring asks what exposure may be doing to a person. Neither question replaces the other—and neither can guarantee safety.Analitička čistoća odgovara na pitanje šta se nalazi u uzorku. Kliničko praćenje pita šta izloženost može činiti osobi. Nijedno pitanje ne zamenjuje drugo—i nijedno ne može garantovati bezbednost.
Blood-pressure elevation, adverse lipid changes, structural cardiac changes and thrombotic or cardiovascular events are central concerns in nonmedical AAS exposure.Povišen krvni pritisak, nepovoljne promene lipida, strukturne promene srca i trombotički ili kardiovaskularni događaji spadaju među glavne rizike nemedicinske izloženosti AAS.
Erythrocytosis, reduced HDL cholesterol, increased atherogenic burden and changes in glucose or fluid balance can compound cardiovascular risk.Eritrocitoza, snižen HDL holesterol, povećano aterogeno opterećenje i promene regulacije glukoze ili tečnosti mogu dodatno pojačati kardiovaskularni rizik.
Exogenous androgens suppress the HPG axis and can reduce intratesticular testosterone and sperm production. Recovery time is variable and may be incomplete.Egzogeni androgeni potiskuju HPG osu i mogu smanjiti intratestikularni testosteron i proizvodnju spermatozoida. Vreme oporavka je promenljivo i oporavak može biti nepotpun.
Risk depends on the compound and exposure. Oral 17α-alkylated agents are particularly relevant to liver injury, while renal and psychiatric effects require broader clinical context.Rizik zavisi od jedinjenja i izloženosti. Oralni 17α-alkilovani agensi posebno su važni za oštećenje jetre, dok bubrežni i psihijatrijski efekti zahtevaju širi klinički kontekst.
Compound mapMapa jedinjenja
This map defines the editorial scope. Detailed profiles will be added compound by compound, with current approval status checked for the relevant jurisdiction instead of inferred from historical medical use.Ova mapa definiše urednički obim. Detaljni profili biće dodavani jedinjenje po jedinjenje, uz proveru aktuelnog statusa odobrenja za relevantnu jurisdikciju, umesto zaključivanja iz istorijske medicinske primene.
Established medical hormone; nonmedical exposure is a different contextUtemeljen medicinski hormon; nemedicinska izloženost je drugačiji kontekst
Medical history and limited indications; 19-nor androgenMedicinska istorija i ograničene indikacije; 19-nor androgen
Oral 17α-alkylated androgen; approval varies by jurisdictionOralni 17α-alkilovani androgen; odobrenje zavisi od jurisdikcije
17α-alkylated androgen with historical medical use17α-alkilovani androgen sa istorijskom medicinskom primenom
Oral androgen with specific historical or regional indicationsOralni androgen sa specifičnim istorijskim ili regionalnim indikacijama
Limited historical therapeutic use; current status variesOgraničena istorijska terapijska primena; aktuelni status varira
Historical oncology use; not broadly used as a modern medicineIstorijska primena u onkologiji; nema široku savremenu medicinsku upotrebu
Veterinary compounds without approved human therapeutic useVeterinarska jedinjenja bez odobrene terapijske primene kod ljudi
AEVANOVA does not provide individual treatment, cycle, dose or sourcing instructions. The purpose of this section is to make mechanisms, medical context, observed nonmedical use, evidence quality and health consequences easier to understand.AEVANOVA ne pruža individualne terapijske smernice, cikluse, doze niti uputstva za nabavku. Cilj ove sekcije je da mehanizme, medicinski kontekst, opaženu nemedicinsku upotrebu, kvalitet dokaza i zdravstvene posledice učini razumljivijim.